Pharma Journalist -

Pharmadax announced that U.S. FDA has approved the generic equivalent of Seroquel XR (quetiapine fumarate) ER tablets, 50 mg, 150 mg, 200 mg, 300 mg and 400 mg, launched by Pharmadex in…
Read More...

Pharmaceutical Product Development (PPD) has expanded its vaccine sciences lab in Richmond, Virginia, to enhance its ability so as to provide industry-leading capabilities to meet…
Read More...

Aduro Biotech announced the expansion of its clinical collaboration with Merck to include an additional Phase 2 clinical trial to evaluate the combination of CRS-207, Aduro’s LADD…
Read More...

Sartorius Stedim Biotech (SSB) and Nova Biomedical has signed a collaboration agreement to integrate their BioProfile FLEX2 into the ambr multi-parallel bioreactor systems for…
Read More...

Kemwell Biopharma announced that it has manufactured and supplied drug substance using its state-of-the-art mammalian cell culture plant in India for clinical trials that will be…
Read More...

Alphaeon announced that it has submitted a BLA (biologic license application) for the Daewoong Botulinum toxin Type A, with the USFDA seeking approval for the treatment of adult…
Read More...

An article published in Experimental Biology and Medicine (Volume 242, Issue 10, May, 2017) identifies a new treatment that may protect the brain from irreversible damage caused by…
Read More...

Maxor National Pharmacy Services announced that Vertex Pharmaceuticals has now included Maxor Specialty in its specialty pharmacy network with immediate effects. Patients may now…
Read More...

Center for Drug Evaluation under China FDA announced that rice-extracted human blood protein is "safe and effective," and its quality can be easily controlled. The Chinese FDA has also…
Read More...

Albireo Pharma announced that USPTO (United States Patent and Trademark Office) has allowed U.S. Patent Application No. 15/276,446, “IBAT inhibitors for the treatment of liver diseases”…
Read More...